The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

After a diagnosis of long COVID, patients in Colorado shifted from seeking care in hospitals and emergency departments (EDs) ...

In a turbulent market environment, SCLX stock has reached a 52-week low, trading at $0.33, with a market capitalization of $62.12 million. This price level reflects a significant downturn for the ...

According to published results, a novel opioid-free pathway may provide noninferior pain management compared with an opioid-containing pathway during the perioperative period in patients undergoing ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

MAXONA Pharmaceuticals today announced that it has emerged from stealth with the completion of the U.S. Phase 1 clinical ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

In recent years, the conversation surrounding cannabis and its medicinal properties has gained considerable momentum.

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

Which provider should runners see for their injuries? It isn't always their M.D. Dr. Jeffrey Sankoff outlines injuries and ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.